Clinical Trials

Phase 2 Not yet recruiting

Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse

NCT07494565 2026-03-27

Celecoxib Plus R-CHOP vs R-CHOP in Newly Diagnosed Advanced CD5+ DLBCL

60 enrolled

Phase 3 Active not recruiting

Lymphoma, Large B-Cell, Diffuse

NCT05888493 2026-03-24

LEDA

109 enrolled

Lymphoma, Follicular, Recurrence

NCT06549595 2026-03-18

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

Phase 3 Recruiting

1,018 enrolled

Lymphoma, Follicular

NCT06517511 2026-02-12

Selinexor in Combination With R-CHOP as the First-line Therapy for TP53-mutated DLBCL Patients (Smart Trial)

Phase 2 Recruiting

42 enrolled

Phase 1/2 Not yet recruiting

Lymphoma, Large B-Cell, Diffuse

NCT07398638 2026-02-10

Lisatoclax Plus R-CHOP or Pola-R-CHP in Untreated DLBCL: A Phase Ib/II Study

122 enrolled

Phase 3 Enrolling by invitation

Lymphoma, Large B-Cell, Diffuse

NCT07348575 2026-01-16

A Multicenter, Prospective, Randomized, Controlled Study of Decitabine in Combination With R-CHOP for Initial Treatment of EBV+ Diffuse Large B-cell Lymphoma

80 enrolled

Phase 1/2 Active not recruiting

Lymphoma, Large B-Cell, Diffuse

NCT04661007 2025-12-18

J-MIND

72 enrolled

Phase 3 Active not recruiting

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

NCT05058404 2025-09-03

Shortened vs Standard Chemotherapy Combined With Immunotherapy for the Initial Treatment of Patients With High Tumor Burden Follicular Lymphoma

605 enrolled

Phase 2 Active not recruiting

Lymphoma, Follicular

NCT04546620 2025-08-06

REMoDL-A

453 enrolled

Phase 2 Active not recruiting

Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

NCT03995147 2025-06-08

Pembrolizumab in Combination With Chemotherapy for Patients With Untreated B Cell Lymphoma

51 enrolled

Lymphoma, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT01865110 2025-03-05

R-CHOP + R-HAD vs R-CHOP Followed by Maintenance Lenalidomide + Rituximab vs Rituximab for Older Patients With MCL

Phase 3 Completed

623 enrolled

Lymphoma, Mantle-Cell

NCT04566887 2025-02-18

Acalabrutinib With R-CHOP in Previously Untreated Mantle Cell Lymphoma

Phase 2 Recruiting

105 enrolled

Lymphoma, Mantle-Cell

NCT06647940 2024-10-22

Orelabrutinib in Combination with R-CHOP for CD5-positive DLBCL Patients（Rocket Trial）

Phase 2 Recruiting

39 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT02633137 2024-08-30

Sequential Chemotherapy and Lenalidomide Followed by Rituximab and Lenalidomide Maintenance for Untreated Mantle Cell Lymphoma

49 enrolled 8 charts

Lymphoma, Mantle-Cell

NCT01843868 2024-08-07

Emesis Control Study in Non-Hodgkin Lymphoma Patients Receiving R-CHOP

Phase NA Withdrawn

Lymphoma, Lymphoma, Non-Hodgkin, Nausea, Vomiting

NCT00268853 2024-05-30

RAPID

124 enrolled 13 charts

Lymphoma, Lymphoma, Large B-Cell, Diffuse

NCT03650933 2024-02-20

A Study Comparing the Efficacy and Safety of G-CHOP Versus R-CHOP in Untreated Diffuse Large B-cell Lymphoma Patients

360 enrolled

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

NCT04263584 2024-01-05

COPA-R-CHOP

62 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT02660710 2022-10-28

Rituximab Plus CHOP Chemotherapy for Diffuse Large B-cell Lymphoma

39 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT04058470 2022-04-14

Toripalimab Plus Rituximab Followed by R-CHOP for Elderly Patients With Untreated Diffused B Cell Lymphoma

Phase 1/2 Unknown

140 enrolled

Lymphoma, Large B-Cell, Diffuse, Pyloric Stenosis, Hypertrophic

NCT02605694 2021-03-17

FRESCO

Phase 2 Withdrawn

Other hematologic neoplasm

Lymphoma

NCT04243434 2020-04-16

PK Study on Ready-to-Use Injection (VSLI-RTU) 1 Vial & 3 Vial Formulation Marqibo® in Hematological Malignant Patients

Phase 1 Unknown

56 enrolled

Hematologic Diseases, Hematologic Neoplasms

NCT02890602 2020-02-20

Erythropoietin for Management of Anemia Caused by Chemotherapy

53 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT00530179 2019-01-22

PET-Chop

Phase NA Completed

69 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT03318835 2017-10-24

Thalidomide Combined With R-CHOP in Newly Diagnosed，Untreated Double-expressor Diffuse Large B-Cell Lymphoma Patients

162 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT00554164 2017-05-05

PETAL

Phase 3 Completed

1,073 enrolled

Lymphoma, Non-Hodgkin

NCT00209209 2017-03-07

MCLelderly

570 enrolled

Lymphoma, Mantle-Cell

NCT02487316 2016-12-30

A Study of Treatment ALK(+) Systemic Anaplastic Large Cell Lymphoma With Crizotinib

Phase 4 Withdrawn

Lymphoma, Large-Cell, Anaplastic

NCT02792491 2016-06-09

Phase II Prospective Trial of Addition of Rituximab to Reduced Dose CHOP Chemotherapy in DLBC L Patients Aged 65 Years and Over

57 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT02054559 2016-02-23

ASPIRE

Phase 3 Withdrawn

Lymphoma, Large B-Cell, Diffuse

NCT01804127 2013-03-05

Interim PET/CT Guided Cycle Numbers of R-CHOP in DLBCL

196 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT00209222 2012-09-10

Efficacy of R-CHOP vs R-CHOP/R-DHAP in Untreated MCL

360 enrolled

Lymphoma, Mantle-Cell

NCT00774826 2011-02-15

Multicentric Study, Three Randomized Arms (R-CVP vs R-CHOP vs R-FM),for Patients With Stage II-IV Follicular Lymphoma

534 enrolled

Lymphoma, Follicular

NCT00466258 2009-11-25

LINFOTARGAM

Phase 4 Completed

50 enrolled

HIV Infections, Lymphoma, Large B-Cell, Diffuse

NCT00946374 2009-07-27

HD-MCL2003

20 enrolled